Literature DB >> 12877986

Striatal proenkephalin gene induction: coordinated regulation by cyclic AMP and calcium pathways.

Christine Konradi1, Wendy Macías, Joshua T Dudman, Richard R Carlson.   

Abstract

Enkephalin modulates striatal function, thereby affecting motor performance and addictive behaviors. The proenkephalin gene is also used as a model to study cyclic AMP-mediated gene expression in striatal neurons. The second messenger pathway leading to proenkephalin expression demonstrates how cyclic AMP pathways are synchronized with depolarization. We show that cyclic AMP-mediated regulation of the proenkephalin gene is dependent on the activity of L-type Ca2+ channels. Inhibition of L-type Ca2+ channels blocks forskolin-mediated induction of proenkephalin. The Ca2+-activated kinase, Ca2+/calmodulin kinase, as well as the cyclic AMP-activated kinase, protein kinase A (PKA), are both necessary for the induction of the proenkephalin promoter. Similarly, both kinases are needed for the L-type Ca2+ channel-mediated induction of proenkephalin. This synchronization of second messenger pathways provides a coincidence mechanism that gates proenkephalin synthesis in striatal neurons, ensuring that levels are increased only in the presence of activated PKA and depolarization.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12877986      PMCID: PMC4205580          DOI: 10.1016/s0169-328x(03)00204-3

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  25 in total

Review 1.  Opioids in chronic pain.

Authors:  R Przewłocki; B Przewłocka
Journal:  Eur J Pharmacol       Date:  2001-10-19       Impact factor: 4.432

2.  Selective reward deficit in mice lacking beta-endorphin and enkephalin.

Authors:  Michael D Hayward; John E Pintar; Malcolm J Low
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

3.  Analysis of the proenkephalin second messenger-inducible enhancer in rat striatal cultures.

Authors:  C Konradi; R L Cole; D Green; P Senatus; J C Leveque; A E Pollack; S J Grossbard; S E Hyman
Journal:  J Neurochem       Date:  1995-09       Impact factor: 5.372

Review 4.  Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior.

Authors:  H Steiner; C R Gerfen
Journal:  Exp Brain Res       Date:  1998-11       Impact factor: 1.972

5.  Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study.

Authors:  C R Gerfen; W S Young
Journal:  Brain Res       Date:  1988-09-13       Impact factor: 3.252

Review 6.  Regulation of neuropeptide release.

Authors:  L L Iversen; C M Lee; R F Gilbert; S Hunt; P C Emson
Journal:  Proc R Soc Lond B Biol Sci       Date:  1980-10-29

7.  Calcium influx via the NMDA receptor induces immediate early gene transcription by a MAP kinase/ERK-dependent mechanism.

Authors:  Z Xia; H Dudek; C K Miranti; M E Greenberg
Journal:  J Neurosci       Date:  1996-09-01       Impact factor: 6.167

8.  Amphetamine and dopamine-induced immediate early gene expression in striatal neurons depends on postsynaptic NMDA receptors and calcium.

Authors:  C Konradi; J C Leveque; S E Hyman
Journal:  J Neurosci       Date:  1996-07-01       Impact factor: 6.167

9.  The cAMP-response-element-binding protein interacts, but Fos protein does not interact, with the proenkephalin enhancer in rat striatum.

Authors:  C Konradi; L A Kobierski; T V Nguyen; S Heckers; S E Hyman
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

10.  Proteins bound at adjacent DNA elements act synergistically to regulate human proenkephalin cAMP inducible transcription.

Authors:  M Comb; N Mermod; S E Hyman; J Pearlberg; M E Ross; H M Goodman
Journal:  EMBO J       Date:  1988-12-01       Impact factor: 11.598

View more
  1 in total

1.  Autocrine activation of neuronal NMDA receptors by aspartate mediates dopamine- and cAMP-induced CREB-dependent gene transcription.

Authors:  Luis E F Almeida; Peter D Murray; H Ronald Zielke; Clinton D Roby; Tami J Kingsbury; Bruce K Krueger
Journal:  J Neurosci       Date:  2009-10-07       Impact factor: 6.167

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.